SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RCMac who wrote (1280)2/3/2000 5:00:00 PM
From: Torben Noerup Nielsen  Read Replies (1) of 2001
 
Well, I've run into Avalon before and with bad results for me so I wouldn't mind getting even!

What's also interesting is that Stephens is focusing *entirely* on ADCON-L growth not being that major because they've supposedly come close to saturation already. First of all, this is strange; I don't think saturation for this kind of product can be reached all that quickly. Second, there's Perceptin and the other ADCONs and they're given *zero* value by implication! Ok, Perceptin isn't on the market, but it should be given some potential value and so should the other ADCONs.

I don't care much for Gliatech's lack of communication either. But Stephens is making my ignore list pretty rapidly. This one is report is so low-grade that someone should have caught it as a matter of quality control.

Thanks, Torben
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News